Inventor · disambiguated record
Clive Mccarthy
Also filed as: MCCARTHY CLIVE
42 granted patents·26 pending applications·208 citations·filing 1994–2025
97Inventor score
Files withNOVARTIS AG13ENTERPRISE THERAPEUTICS LTD7ADORX THERAPEUTICS LTD6BOEHRINGER INGELHEIM INT6AVENTIS PHARMA LTD5
Top patents by PatentIndex Score
68 records- 0186US8865894B2Oxazolidin-2-one compounds and uses thereofNOVARTIS AG·Filed 2013·Granted Oct 21, 2014·10 cites·22 claims
- 0285US12037336B2Compounds with activity as inhibitors of the epithelial sodium channel (ENaC)ENTERPRISE THERAPEUTICS LTD·Filed 2019·Granted Jul 16, 2024·3 cites·30 claims
- 0385US6608084B1Aza-bicycles which modulate the inhibition of cell adhesionAVENTIS PHARMA LTD·Filed 1999·Granted Aug 19, 2003·67 cites·38 claims
- 0484US8389526B23-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivativesFURET PASCAL·Filed 2010·Granted Mar 5, 2013·4 cites·9 claims
- 0583US9845314B2Pyrazolyl-substituted heteroaryls and their use as medicamentsBOEHRINGER INGELHEIM INT·Filed 2016·Granted Dec 19, 2017·4 cites·31 claims
- 0682US6706738B2Substituted bicyclic heteroaryl compounds and their use as integrin antagonistsAVENTIS PHARMA LTD·Filed 2001·Granted Mar 16, 2004·20 cites·19 claims
- 0780US11364246B2CompoundsTMEM16A LTD·Filed 2019·Granted Jun 21, 2022·2 cites·11 claims
- 0877US12371436B2Substituted benzodiazoliums as ENaC inhibitorsENTERPRISE THERAPEUTICS LTD·Filed 2023·Granted Jul 29, 2025·0 cites·24 claims
- 0977US8030311B2Phenylacetamides suitable as protein kinase inhibitorsNOVARTIS AG·Filed 2006·Granted Oct 4, 2011·2 cites·10 claims
- 1076US2025304590A1Benzodiazolium compounds as enac inhibitorsENTERPRISE THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 1175US7273875B2Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (PDE4) inhibitorsNOVARTIS AG·Filed 2002·Granted Sep 25, 2007·10 cites·14 claims
- 1274US8912173B2Substituted quinolines and their use as medicamentsHOFFMANN MATTHIAS·Filed 2012·Granted Dec 16, 2014·3 cites·35 claims
- 1374US7947730B2Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptorNOVARTIS AG·Filed 2004·Granted May 24, 2011·7 cites·9 claims
- 1474US6562851B2Substituted bicyclic compoundsAVENTIS PHARMA LTD·Filed 2001·Granted May 13, 2003·8 cites·22 claims
- 1572US8822468B23-Methyl-imidazo[1,2-b]pyridazine derivativesFURET PASCAL·Filed 2009·Granted Sep 2, 2014·2 cites·3 claims
- 1672US7687637B25-phenylthiazole derivatives and use as Pi3 kinase inhibitorsNOVARTIS AG·Filed 2003·Granted Mar 30, 2010·7 cites·14 claims
- 1771US6124343ASubstituted phenyl compounds with a substituent having a thienyl ringRHONE POULENC RORER LTD·Filed 1997·Granted Sep 26, 2000·12 cites·19 claims
- 1870US8129541B25-phenylthiazole derivatives and use as PI3 kinase inhibitorsBRUCE IAN·Filed 2009·Granted Mar 6, 2012·1 cites·15 claims
- 1970US7468370B2[1,7]naphthyridines as PDE4 inhibitorsNOVARTIS AG·Filed 2003·Granted Dec 23, 2008·6 cites·10 claims
- 2070US6211234B1Substituted phenyl compoundsRHONE POULENC RORER LTD·Filed 1994·Granted Apr 3, 2001·26 cites·20 claims
- 2169US6593354B2Substituted benzoxazole compoundsAVENTIS PHARMA LTD·Filed 2001·Granted Jul 15, 2003·4 cites·24 claims
- 2268US8466289B2Heterocyclic sulfonamide derivativesBOCK MARK G·Filed 2010·Granted Jun 18, 2013·2 cites·11 claims
- 2366US11739094B2Substituted benzodiazoliums as ENaC inhibitorsENTERPRISE THERAPEUTICS LTD·Filed 2020·Granted Aug 29, 2023·0 cites·26 claims
- 2465US10947243B2Heteroaryl SYK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Mar 16, 2021·0 cites·2 claims
- 2564US7902375B25-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylin ositol 3 kinase enzymes (PI13) for treatment of inflammatory diseasesNOVARTIS AG·Filed 2004·Granted Mar 8, 2011·1 cites·2 claims
- 2663US7288537B2Azetidine derivatives as CCR-3 receptor antagonistsNOVARTIS AG·Filed 2003·Granted Oct 30, 2007·4 cites·19 claims
- 2763US2025243194A1Antagonist of adenosine receptorsADORX THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 2862US10941149B2Substituted benzodiazoliums as ENaC inhibitorsENTERPRISE THERAPEUTICS LTD·Filed 2017·Granted Mar 9, 2021·0 cites·21 claims
- 2961US12377105B2CompoundsTMEM16A LTD·Filed 2022·Granted Aug 5, 2025·0 cites·14 claims
- 3059US2024132467A1Benzimidazole derivatives for treating respiratory diseaseTMEM16A LTD·Filed 2023·Application pending·0 cites
- 3158US2020030290A1Indazole and indole derivatives as inhibitors of retinoic acid related orphan receptor gamma (ror gamma) for the treatment of immune-related diseasesORCA PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 3258US2025340565A1Cd73 inhibitor compoundsADORX THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 3355US9861612B2Indolyl-containing RORγt inhibitorsORCA PHARMACEUTICALS LTD·Filed 2016·Granted Jan 9, 2018·0 cites·13 claims
- 3453US9522134B2CompoundsORCA PHARMACEUTICALS LTD·Filed 2016·Granted Dec 20, 2016·0 cites·6 claims
- 3553US9199937B2Substituted quinolines and their use as medicamentsBOEHRINGER INGELHEIM INT·Filed 2014·Granted Dec 1, 2015·0 cites·5 claims
- 3653US2023293517A1Antagonist compoundsADORX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 3752US9458177B2Oxazolidin-2-one compounds and uses thereofCARAVATTI GIORGIO·Filed 2014·Granted Oct 4, 2016·0 cites·29 claims
- 3851US2023203029A1Naphthyridine compounds as inhibitors of mer tyrosine kinase and axl tyrosine kinaseKINSENSUS LTD·Filed 2021·Application pending·0 cites
- 3950US10155751B2Pyrazolyl-substituted heteroaryls and their use as medicamentsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Dec 18, 2018·0 cites·11 claims
- 4050US2018072744A1Heteroaryl syk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 4150US2024083904A1Antagonists of the adenosine a2a receptorADORX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 4249US9914735B2Heteroaryl Syk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2015·Granted Mar 13, 2018·0 cites·10 claims
- 4349US2011124693A15-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory diseasesBLOOMFIELD GRAHAM CHARLES·Filed 2011·Application pending·0 cites
- 4449US2011124624A15-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory diseasesBLOOMFIELD GRAHAM CHARLES·Filed 2011·Application pending·0 cites
- 4549US2009275606A1Heterocyclic Compounds as MEK InhibitorsNOVARTIS AG·Filed 2009·Application pending·0 cites
- 4648US10383850B2Indazole and indole derivatives as inhibitors of retinoic acid related orphan receptor gamma (ROR gamma) for the treatment of immune-related diseasesORCA PHARMACEUTICALS LTD·Filed 2015·Granted Aug 20, 2019·0 cites·14 claims
- 4747US6048893ASubstituted phenyl compounds with a substituent having A 1,3-benzodioxole ringRHONE POULENC RORER LTD·Filed 1999·Granted Apr 11, 2000·3 cites·23 claims
- 4847US2023203041A1Antagonists of the adenosine a2a receptorADORX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 4946US2009023769A1Organic CompoundsNOVARTIS AG·Filed 2007·Application pending·0 cites
- 5045US2012184561A1Phenylacetamides suitable as protein kinase inhibitorsBOLD GUIDO·Filed 2011·Application pending·0 cites
Showing the top 50 of 68 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Clive Mccarthy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →